Article info

Download PDFPDF

Protocol
Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol

Authors

  1. Correspondence to Dr Rinki Murphy; r.murphy{at}auckland.ac.nz
View Full Text

Citation

Yeu RQ, Brandon R, Jiang Y, et al
Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol

Publication history

  • Received December 20, 2019
  • Revised July 2, 2020
  • Accepted July 8, 2020
  • First published September 1, 2020.
Online issue publication 
September 01, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.